Golimurel 50mg Injection contains an active component as Golimumab. It is a monoclonal antibody drug used to treat autoimmune diseases, particularly certain inflammatory conditions. It works by targeting and inhibiting a certain protein, which plays a role in causing inflammation in the body. It is used to treat moderate to severe rheumatoid arthritis in adults, often in combination with other disease-modifying antirheumatic drugs (DMARDs). It is also approved for treating psoriatic arthritis, an autoimmune condition affecting joints and skin. It can treat ankylosing spondylitis, a type of arthritis primarily affecting the spine and sacroiliac joints. One of the advantages of this medication is that it offers relatively long dosing intervals compared to other biological medications. 

Golimurel 50mg Injection should not be used in patients with known hypersensitivity or severe allergic reactions to the drug. Allergic reactions can be life-threatening and may include symptoms such as rash, itching, swelling, severe dizziness, and difficulty breathing. This medication can suppress the immune system, making patients more susceptible to infections. Individuals with active infections should start treatment once the infection is resolved. Individuals with a history of hepatitis B infection should require close monitoring before starting treatment, as the virus can reactivate during treatment. Patients with a history of heart failure or other significant cardiovascular conditions require close monitoring. Golimurel 50mg Injection's safety and efficacy in pediatric patients may differ from its use in adults. Older individuals may be at a higher risk of osteoporosis and fractures. The impact of this medication on bone health should be monitored, especially if the patient is already at risk. Patients with kidney impairment may require dose adjustments, as the clearance of these medications, is affected by impaired kidney function.

Golimurel 50mg Injection is used in the treatment of the following:

• Rheumatoid arthritis

• Psoriatic arthritis

• Ankylosing spondylitis

• Axial spondyloarthritis

• Ulcerative colitis

• Juvenile idiopathic arthritis

Golimumab in Golimurel 50mg Injection exerts its therapeutic effect through its role as a tumor necrosis factor-alpha (TNF-alpha) inhibitor. TNF-alpha is a cytokine involved in promoting inflammation and immune responses. This medication binds to soluble and transmembrane forms of TNF-alpha, preventing their interaction with cell surface receptors and dampening the downstream inflammatory signalling pathways. By inhibiting TNF-alpha, this medication helps reduce inflammation, alleviate symptoms, and slow the progression of autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.

Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Golimurel 50mg Injection, reducing effectiveness by causing undesirable side effects.

• Stored in a refrigerator at a temperature between 2°C to 8°C.

• Keep away from moisture, heat, and light.

• It should not be frozen.

• Keep away from children and pets.

Golimurel 50mg Injection is typically administered as a subcutaneous injection, which involves injecting the medication under the skin. The exact method of administration may vary depending on the specific formulation and manufacturer. Patients are often instructed to use a pre-filled syringe or an auto-injector device provided with the medication. Before self-administering, patients should follow the instructions provided by their healthcare provider and the medication's package insert.

Golimurel 50mg Injection causes some side effects like all medications, although not everyone will experience them. 

Serious

• Allergic reactions

• Elevated liver enzymes

• Blood disorders

• Immunosupression

Common

• Injection site reactions (pain, redness, swelling)

• Upper respiratory tract infections (e.g., common cold)

• Headache

• Elevated liver enzymes

• Nausea

• Rash or skin reactions

• Upper abdominal pain

• Sinusitis

• Urinary tract infections

• You do not have any active infections before starting treatment with Golimurel 50mg Injection.

• Regular monitoring of liver function and blood counts is recommended throughout the course of treatment.

• Inform your doctor if you have a history of heart failure, neurological disorders, cancer, or if you require live vaccines.

• Stay alert for any signs of allergic reactions during treatment and report them immediately to your doctor.

• Pediatric and elderly patients should be closely monitored due to specific risks and required precautions.

• Share your complete medical history, current medications, and concerns with your healthcare provider to support safe and informed treatment decisions.

1. Janssen Biologics BV, Electronic medicines compendium (emc), [Revised on Oct 2020] [Accessed on 25th August 2023], https://www.medicines.org.uk/emc/files/pil.5707.pdf

2. Janssen Biotech, US Food and Drug Administration, [Revised on August 2011] [Accessed on 25th August 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/125289s0064lbl.pdf

3. Eleftherios Pelechas eta l; golimumab for Rheumatoid Arthritis; Journal of Clinical Medicine; [Published on March 2019]; [Accessed on 25/08/2023]; http://www.ncbi.nlm.nih.gov/pmc/articles/pmc6463251/